Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Long Island Vitreoretinal Consultants
492
mi
from 43215
Great Neck, NY
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Long Island Vitreoretinal Consultants
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Long Island
494
mi
from 43215
Lynbrook, NY
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
494
mi
from 43215
Lynbrook, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western NY
355
mi
from 43215
Rochester, NY
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western NY
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Island Retina
537
mi
from 43215
Shirley, NY
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Island Retina
537
mi
from 43215
Shirley, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Lancaster Retina Specialists
355
mi
from 43215
Lancaster, PA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Lancaster Retina Specialists
355
mi
from 43215
Lancaster, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Mid-Atlantic Retina
416
mi
from 43215
Philadelphia, PA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Mid-Atlantic Retina
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Associates in Ophthalmalogy
168
mi
from 43215
West Mifflin, PA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Associates in Ophthalmalogy
168
mi
from 43215
West Mifflin, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Carolina
354
mi
from 43215
Greenville, SC
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Carolina
354
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Charleston Neuroscience Institute
508
mi
from 43215
Ladson, SC
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Charleston Neuroscience Institute
508
mi
from 43215
Ladson, SC
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Research Institute of Texas, LLC
1070
mi
from 43215
Abilene, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Research Institute of Texas, LLC
1070
mi
from 43215
Abilene, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
928
mi
from 43215
Arlington, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
928
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Texan Eye Care
1065
mi
from 43215
Austin, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Texan Eye Care
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
905
mi
from 43215
Dallas, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Houston Eye Associates
997
mi
from 43215
Houston, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Houston Eye Associates
997
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous of Texas
991
mi
from 43215
Houston, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous of Texas
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Houston
991
mi
from 43215
Houston, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Houston
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
San Antonio Eye Center
1138
mi
from 43215
San Antonio, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
San Antonio Eye Center
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Medical Center Ophthalmology Associates
1138
mi
from 43215
San Antonio, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Medical Center Ophthalmology Associates
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of San Antonio
1138
mi
from 43215
San Antonio, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of San Antonio
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
971
mi
from 43215
The Woodlands, TX
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
971
mi
from 43215
The Woodlands, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Utah
1513
mi
from 43215
Salt Lake City, UT
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Utah
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Institute of Virginia
338
mi
from 43215
Richmond, VA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Institute of Virginia
338
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Hospital Universitario Austral
5386
mi
from 43215
Buenos Aires,
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Hospital Universitario Austral
5386
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Thomas Eye Group
424
mi
from 43215
Sandy Springs, GA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Thomas Eye Group
424
mi
from 43215
Sandy Springs, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University Retina and Macula Associates, P.C.
271
mi
from 43215
Oak Forest, IL
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University Retina and Macula Associates, P.C.
271
mi
from 43215
Oak Forest, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Kellogg Eye Center
167
mi
from 43215
Ann Arbor, MI
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Kellogg Eye Center
167
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Carolina Eye Associates
386
mi
from 43215
Southern Pines, NC
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Carolina Eye Associates
386
mi
from 43215
Southern Pines, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Apex Eye Clinical Research
92
mi
from 43215
Fairfield, OH
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Apex Eye Clinical Research
92
mi
from 43215
Fairfield, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Piedmont Eye Center, Inc.
274
mi
from 43215
Lynchburg, VA
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Piedmont Eye Center, Inc.
274
mi
from 43215
Lynchburg, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Arizona Retina and Vitreous Consultants
1662
mi
from 43215
Phoenix, AZ
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Arizona Retina and Vitreous Consultants
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Hawaii
4502
mi
from 43215
'Aiea, HI
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Hawaii
4502
mi
from 43215
'Aiea, HI
Click here to add this to my saved trials
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
306
mi
from 43215
Winston-Salem, NC
A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated:  12/31/1969
Sall Research Medical Center, Inc.
1968
mi
from 43215
Artesia, CA
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Sall Research Medical Center, Inc.
1968
mi
from 43215
Artesia, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated:  12/31/1969
North Valley Eye Medical Group, Inc.
1978
mi
from 43215
Mission Hills, CA
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated: 12/31/1969
North Valley Eye Medical Group, Inc.
1978
mi
from 43215
Mission Hills, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated:  12/31/1969
Comprehensive Eye Care Ltd
437
mi
from 43215
Washington, MO
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Comprehensive Eye Care Ltd
437
mi
from 43215
Washington, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated:  12/31/1969
Total Eye Care, PA
508
mi
from 43215
Memphis, TN
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
Status: Enrolling
Updated: 12/31/1969
Total Eye Care, PA
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1960
mi
from 43215
Arcadia, CA
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1960
mi
from 43215
Arcadia, CA
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1979
mi
from 43215
Beverly Hills, CA
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1882
mi
from 43215
Palm Desert, CA
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1882
mi
from 43215
Palm Desert, CA
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1063
mi
from 43215
Abilene, TX
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1063
mi
from 43215
Abilene, TX
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2023
mi
from 43215
Silverdale, WA
Study of DS-7080a for the Treatment of Macular Degeneration
Phase I Dose Escalation and Expansion Study of DS-7080a in Subjects With Neovascular Age-related Macular Degeneration or Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2023
mi
from 43215
Silverdale, WA
Click here to add this to my saved trials
A Prospective Observational Study of Adult Strabismus
A Prospective Observational Study of Adult Strabismus
Status: Enrolling
Updated:  12/31/1969
Earl R. Crouch, III
426
mi
from 43215
Norfolk, VA
A Prospective Observational Study of Adult Strabismus
A Prospective Observational Study of Adult Strabismus
Status: Enrolling
Updated: 12/31/1969
Earl R. Crouch, III
426
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials